Systemic absorption of gentamicin ear drops

K M Green1, D W Lappin, J W Curley

  • 1Department of Otolaryngology, Royal Preston Hospital, UK.

Insights

Topical aminoglycosides treat ear infections but can be absorbed systemically. A case study found significant gentamicin levels in the blood after using Gentisone HC for ear conditions.

Area of Science:

  • Otolaryngology
  • Pharmacology
  • Dermatology

Background:

  • Topical aminoglycosides are frequently prescribed for chronic suppurative otitis media and otitis externa.
  • These preparations are generally considered safe for localized treatment.

Observation:

  • A patient using a topical aminoglycoside preparation, Gentisone HC, experienced unintended systemic absorption.
  • This resulted in a measurable serum gentamicin concentration.

Findings:

  • Serum gentamicin levels reached 6.2 micrograms/ml, indicating significant systemic uptake.
  • This highlights a potential risk associated with topical aminoglycoside use.

Implications:

  • Clinicians should be aware of the potential for systemic absorption of topical aminoglycosides.
  • Monitoring serum levels may be warranted in specific patient populations or with prolonged use.
  • This case underscores the importance of considering systemic effects even with topical medications.

Related Concept Videos

Drug Elimination by Renal Route: Tubular Secretion01:15

Drug Elimination by Renal Route: Tubular Secretion

Once the process of glomerular filtration is completed, blood carrying unfiltered drug molecules traverses through efferent arterioles and makes its way into the peritubular capillaries in the proximal tubule. A variety of carriers play a pivotal role in actively secreting drugs from these peritubular capillaries into the tubular fluid. The organic anion transporter transfers acidic drugs, against an electrochemical gradient, from the peritubular capillaries into the renal tubule cells and...
Factors Influencing Drug Absorption: Presystemic Elimination01:24

Factors Influencing Drug Absorption: Presystemic Elimination

The pharmacokinetic journey of oral drugs begins with a crucial first pass through the hepatic portal system, called the first-pass effect. This first pass significantly impacts bioavailability — the proportion of a drug that enters systemic circulation and is available for therapeutic action. The primary route sees the drug absorbed by intestinal membranes and then shunted to the liver via the hepatic portal vein. Here, pre-systemic elimination occurs as drugs face metabolism or biliary...
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
Ophthalmic Drug Delivery Systems01:23

Ophthalmic Drug Delivery Systems

Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...